EUVIMEDEUVIMED entdecken
ÜbersichtsarbeitOpen Access · CC BY 4.0

The Transcription Factor HOXA5: Novel Insights into Metabolic Diseases and Adipose Tissue Dysfunction

Luca Parrillo iD, Rosa Spinelli iD, Michele Longo iD, Federica Zatterale iD, Gianluca Santamaria iD, Alessia Leone, Michele Campitelli, Gregory Alexander Raciti iD, Francesco Beguinot

Cells · 2023

DOI: 10.3390/cells12162090 ↗

Kurz gefasst

Übersichtsarbeit in der Zeitschrift Cells, 2023. Verfasst von Luca Parrillo und 8 weiteren Autor:innen. Beteiligte Einrichtung: URT Genomics of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, Department of Translational Medical Scienc…. Hauptthemen laut MEDLINE: Diabetes Mellitus, Type 2, Metabolic Diseases. Die Arbeit wurde bisher 21-mal zitiert (Crossref) und nennt 98 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: Ministero dell’Università e della Ricerca, Ministero della Salute.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

The transcription factor HOXA5, from the HOX gene family, has long been studied due to its critical role in physiological activities in normal cells, such as organ development and body patterning, and pathological activities in cancer cells. Nonetheless, recent evidence supports the hypothesis of a role for HOXA5 in metabolic diseases, particularly in obesity and type 2 diabetes (T2D). In line with the current opinion that adipocyte and adipose tissue (AT) dysfunction belong to the group of primary defects in obesity, linking this condition to an increased risk of insulin resistance (IR) and T2D, the HOXA5 gene has been shown to regulate adipocyte function and AT remodeling both in humans and mice. Epigenetics adds complexity to HOXA5 gene regulation in metabolic diseases. Indeed, epigenetic mechanisms, specifically DNA methylation, influence the dynamic HOXA5 expression profile. In human AT, the DNA methylation profile at the HOXA5 gene is associated with hypertrophic obesity and an increased risk of developing T2D. Thus, an inappropriate HOXA5 gene expression may be a mechanism causing or maintaining an impaired AT function in obesity and potentially linking obesity to its associated disorders. In this review, we integrate the current evidence about the involvement of HOXA5 in regulating AT function, as well as its association with the pathogenesis of obesity and T2D. We also summarize the current knowledge on the role of DNA methylation in controlling HOXA5 expression. Moreover, considering the susceptibility of epigenetic changes to reversal through targeted interventions, we discuss the potential therapeutic value of targeting HOXA5 DNA methylation changes in the treatment of metabolic diseases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Diabetes Mellitus, Type 2Metabolic DiseasesHumansAnimalsMiceTranscription FactorsGenes, HomeoboxAdipose TissueObesityHomeodomain Proteins

Stichwörter der Autor:innen

DNA methylationHOX genesadipogenesisadipose tissue dysfunctionepigenetic biomarkerepigeneticsfat mass distributionhypertrophic obesityinflammationmetabolic diseasesobesity and type 2 diabetestargeted therapy

Substanzen

Transcription FactorsHOXA5 protein, humanHomeodomain Proteins

Autor:innen und Institutionen

  • URT Genomics of Diabetes, Institute of Experimental Endocrinology and Oncology, National Research Council, Department of Translational Medical Sciences, Federico II University of Naples, 80131 Naples, Italy.
  • Lundberg Laboratory for Diabetes Research, Department of Molecular and Clinical Medicine, Sahlgrenska Academy, University of Gothenburg, 41345 Gothenburg, Sweden.
  • Department of Experimental and Clinical Medicine, University Magna Græcia of Catanzaro, 88100 Catanzaro, Italy.

ORCID-Profile: Luca Parrillo, Rosa Spinelli, Michele Longo, Federica Zatterale, Gianluca Santamaria, Gregory Alexander Raciti

Förderung

  • Ministero dell’Università e della Ricerca
  • Ministero della Salute

Zitieren

APA

Parrillo, L., Spinelli, R., Longo, M., Zatterale, F., Santamaria, G., Leone, A., Campitelli, M., Raciti, G. A., & Beguinot, F. (2023). The Transcription Factor HOXA5: Novel Insights into Metabolic Diseases and Adipose Tissue Dysfunction. Cells. https://doi.org/10.3390/cells12162090

Vancouver

Parrillo L, Spinelli R, Longo M, Zatterale F, Santamaria G, Leone A, et al. The Transcription Factor HOXA5: Novel Insights into Metabolic Diseases and Adipose Tissue Dysfunction. Cells. 2023. doi:10.3390/cells12162090

BibTeX
@article{Parrillo2023,
  author = {Parrillo, Luca and Spinelli, Rosa and Longo, Michele and Zatterale, Federica and Santamaria, Gianluca and Leone, Alessia and Campitelli, Michele and Raciti, Gregory Alexander and Beguinot, Francesco},
  title = {The Transcription Factor HOXA5: Novel Insights into Metabolic Diseases and Adipose Tissue Dysfunction},
  journal = {Cells},
  year = {2023},
  doi = {10.3390/cells12162090}
}
Kostenlos starten →